InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain
InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy IRX-211 for treatment of Breakthrough Cancer Pain
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
TUC | Ann: ASX Code Change | 08/01/14 | 2 | 1.2K | |||
|
|||||||
TUC | Ann: Results of Meeting | 18/12/13 | 0 | 352 | |||
|
|||||||
TUC | Ann: Becoming a substantial holder | 17/12/13 | 0 | 349 | |||
|
|||||||
TUC | Ann: Change of Director's Interest Notice | 16:02 | 0 | 312 | |||
|
|||||||
TUC | Ann: Section 708A Notice | 16:01 | 0 | 371 | |||
|
|||||||
TUC | Ann: Appendix 3B | 16:00 | 0 | 195 | |||
|
|||||||
TUC | Ann: ASX Waiver granted | 02/12/13 | 0 | 279 | |||
|
|||||||
TUC | Ann: Investor Update Presentation | 21/11/13 | 0 | 322 | |||
|
See All Discussions